EX1 0.00% 1.1¢ exopharm limited

Ann: Preclinical Data from Osteoarthritis Animal Study, page-25

  1. 4,283 Posts.
    lightbulb Created with Sketch. 13
    https://hotcopper.com.au/data/attachments/3056/3056490-406463e75cab3343a947bbb42ef831ff.jpg

    Google Ventures was in the latest Series C raise. Google Ventures also has an extremely high rate of exits. Also I think CDAK has bottomed and I am betting the bottom for EX1 is close. Either way the IP for EX1 is more then $80m market cap is my feel but they still have a lot to go to prove themselves.
 
watchlist Created with Sketch. Add EX1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.